Medpace Voice

Explore several of the key themes emerging from ESCMID Global 2026.

Mental health disorders affect an estimated one billion people worldwide, contributing to profound personal, social, and economic burden. As the World Health Organization notes, most…

Authors: Carmen Gasca-Salas, MD, MSc, PhD, Medical Director, Medpace  Recently, the Medpace neuroscience team attended the AD/PD (Alzheimer’s & Parkinson’s Disease)...

As a Hematologist/Oncologist, I have always been a life-long advocate of the rigor and structure of a clinical trial. That...

In this newly published episode of Seamless Insights: The Podcast, Hamish Baird, President of Remington Davis, sits down with Medpace...

Authors: James Vornov MD, PhD and Jessica Yehnert Recently, the Medpace stroke team attended ISC (International Stroke Conference). Among the many presentations, one study in...

March 4th marks World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the...

Rare disease clinical development is undergoing rapid transformation, driven by scientific innovation, evolving regulatory frameworks, and the need for more flexible, patient-centric trial designs.

Successfully executing a C-QTc analysis requires the seamless integration of specialized clinical operations, technical ECG expertise, advanced biometrics, and focused reporting. Learn more.

IDWeek 2025 marked a pivotal moment in the evolution of infectious diseases (ID) research and pharmaceutical innovation. Beyond its traditional...